Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

A Reassessment of the Impact of European Contact on the Structure of Native American Genetic Diversity.

Hunley K, Gwin K, Liberman B.

PLoS One. 2016 Aug 31;11(8):e0161018. doi: 10.1371/journal.pone.0161018.

2.

The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.

Wolsky RJ, Harbour LN, Mirza KM, Montag AG, Gwin K.

Appl Immunohistochem Mol Morphol. 2016 Aug 3. [Epub ahead of print]

PMID:
27490766
3.

Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.

Xu Z, Gwin KA, Li Y, Medina KL.

BMC Immunol. 2016 Jun 10;17(1):16. doi: 10.1186/s12865-016-0152-1.

4.

Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis.

Fata CR, Seeley EH, Desouki MM, Du L, Gwin K, Hanley KZ, Hecht JL, Jarboe EA, Liang SX, Parkash V, Quick CM, Zheng W, Shyr Y, Caprioli RM, Fadare O.

Hum Pathol. 2015 Oct;46(10):1427-36. doi: 10.1016/j.humpath.2015.06.009.

PMID:
26243671
5.

Cell extrinsic alterations in splenic B cell maturation in Flt3-ligand knockout mice.

Dolence JJ, Gwin KA, Shapiro MB, Hsu FC, Shapiro VS, Medina KL.

Immun Inflamm Dis. 2015 Jun;3(2):103-17. doi: 10.1002/iid3.54.

6.
7.

Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.

Buell-Gutbrod R, Cavallo A, Lee N, Montag A, Gwin K.

Int J Gynecol Pathol. 2015 Jan;34(1):65-73. doi: 10.1097/PGP.0000000000000106.

PMID:
25473755
8.

The expression of FOXL2 in pancreatic, hepatobiliary, and renal tumors with ovarian-type stroma.

Westerhoff M, Tretiakova M, Hart J, Gwin K, Liu X, Zhou M, Yeh MM, Antic T.

Hum Pathol. 2014 May;45(5):1010-4. doi: 10.1016/j.humpath.2013.12.015.

PMID:
24746205
9.

Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors.

Dolence JJ, Gwin KA, Shapiro MB, Medina KL.

Exp Hematol. 2014 May;42(5):380-393.e3. doi: 10.1016/j.exphem.2014.01.001.

10.

Separation of plasmacytoid dendritic cells from B-cell-biased lymphoid progenitor (BLP) and Pre-pro B cells using PDCA-1.

Medina KL, Tangen SN, Seaburg LM, Thapa P, Gwin KA, Shapiro VS.

PLoS One. 2013 Oct 30;8(10):e78408. doi: 10.1371/journal.pone.0078408.

11.

Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.

Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Parkash V, Hecht JL.

Am J Surg Pathol. 2014 Feb;38(2):189-96. doi: 10.1097/PAS.0000000000000085.

PMID:
24145649
12.

Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.

Zhao L, Antic T, Witten D, Paner GP, Taxy JB, Husain A, Gwin K, Mirza MK, Lingen MW, Tretiakova MS.

Am J Surg Pathol. 2013 Dec;37(12):1876-81. doi: 10.1097/PAS.0b013e31829e2525.

PMID:
24121175
13.

Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Fadare O, Parkash V, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Rawish KR, Hecht JL, Desouki MM.

Hum Pathol. 2013 Dec;44(12):2814-21. doi: 10.1016/j.humpath.2013.07.033.

14.

Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.

Zhang Y, Kenny HA, Swindell EP, Mitra AK, Hankins PL, Ahn RW, Gwin K, Mazar AP, O'Halloran TV, Lengyel E.

Mol Cancer Ther. 2013 Dec;12(12):2628-39. doi: 10.1158/1535-7163.MCT-13-0204.

15.

Hoxa9 and Flt3 signaling synergistically regulate an early checkpoint in lymphopoiesis.

Gwin KA, Shapiro MB, Dolence JJ, Huang ZL, Medina KL.

J Immunol. 2013 Jul 15;191(2):745-54. doi: 10.4049/jimmunol.1203294.

16.

Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei.

Buell-Gutbrod R, Gwin K.

Am Soc Clin Oncol Educ Book. 2013:221-5. doi: 10.1200/EdBook_AM.2013.33.221. Review.

17.

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.

Fadare O, Gwin K, Desouki MM, Crispens MA, Jones HW 3rd, Khabele D, Liang SX, Zheng W, Mohammed K, Hecht JL, Parkash V.

Mod Pathol. 2013 Aug;26(8):1101-10. doi: 10.1038/modpathol.2013.35.

18.

Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance.

Fadare O, Liang SX, Crispens MA, Jones HW 3rd, Khabele D, Gwin K, Zheng W, Mohammed K, Parkash V, Hecht JL, Desouki MM.

Hum Pathol. 2013 Aug;44(8):1508-15. doi: 10.1016/j.humpath.2012.12.003.

19.

Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors.

Gwin K, Dolence JJ, Shapiro MB, Medina KL.

BMC Immunol. 2013 Jan 30;14:5. doi: 10.1186/1471-2172-14-5.

20.

Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases.

Fadare O, Zheng W, Crispens MA, Jones HW, Khabele D, Gwin K, Liang SX, Mohammed K, Desouki MM, Parkash V, Hecht JL.

Am J Cancer Res. 2013;3(1):70-95.

Items per page

Supplemental Content

Support Center